| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |